Estudo de compatibilidade entre cafeína, dipirona e citrato de orfenadrina
| Ano de defesa: | 2016 |
|---|---|
| Autor(a) principal: | |
| Orientador(a): | |
| Banca de defesa: | , |
| Tipo de documento: | Dissertação |
| Tipo de acesso: | Acesso aberto |
| Idioma: | por |
| Instituição de defesa: |
Universidade Estadual da Paraíba
|
| Programa de Pós-Graduação: |
Programa de Pós-Graduação em Ciências Farmacêuticas - PPGCF
|
| Departamento: |
Pró-Reitoria de Pós-Graduação e Pesquisa - PRPGP
|
| País: |
BR
|
| Palavras-chave em Português: | |
| Palavras-chave em Inglês: | |
| Área do conhecimento CNPq: | |
| Link de acesso: | https://repositorio.uepb.edu.br/handle/123456789/73284 |
Resumo: | The development of a new pharmaceutical form involves a number of preliminary analyzes, which constitute the pre-formulation study, which will be gathered information about the physical, chemical and mechanical properties of the formulation constituents. Therefore, it is necessary to investigate the compatibility of active pharmaceutical ingredients and excipients of the final product by means of thermoanalytical and non-thermal techniques as possible interactions can alter and compromise the efficacy, safety and quality of the product. Therefore, the primary objective of this study is to assess the compatibility of the active pharmaceutical inputs dipyrone, and caffeine citrate orfenandrina each other and excipients. The differential scanning calorimetry (DSC) was performed in ratios of 2, 5 and 10 ° C / min^-1, coupled with differential thermal analysis (DTA), infrared spectroscopy (FTIR) and x-ray diffraction (XRD). All DSC curves were obtained melting points of the active pharmaceutical ingredients, especi ally the values of the melting point found in the heating rate of 2 ° C / min, which were 237.75 ° C, 222.36 ° C and 140 , 41 ° C for caffeine, dipyrone and orphenadrine citrate, respectively. While, in the cooling curves was not identified any polymorphism. The quaternary DTA curves evaluated aerosil selection at the expense of pregelatinized starch and microcrystalline cellulose 101. From the curves of the binary mixture, those containing dipyrone showed greater mismatch indication, whereas the mixtures of the active pharmaceutical ingredients from themselves were compatible, since the characteristic peaks thereof were identified without changing considerably, its thermal events. In the infrared spectra there is a chemical interaction of carboxymethylcellulose with caffeine, moreover, the spectra containing the binary mixtures dipyrone there was suppression on the free hydroxyl bands glycolate starch, carboxymethylcellulose, starch and croscarmellose sodium, a similar result occurred with the starch glycolate opposite orphenadrine citrate. The XRD patterns did not identify displacement or removal of significant robins to characterize some sort of incompatibility. Through evaluation by different analytical techniques across the various preparations, it was observed that the IFA may be sold simultaneously in view of their physical and chemical compatibility. |
| id |
UEPB-2_94e77d0c44cb43dceaae99f50bc02c1e |
|---|---|
| oai_identifier_str |
oai:repositorio.uepb.edu.br:123456789/73284 |
| network_acronym_str |
UEPB-2 |
| network_name_str |
Repositório Institucional da Universidade Estadual da Paraíba (UEPB) |
| repository_id_str |
|
| spelling |
2018-04-23T20:27:02Z2026-02-27T10:26:53Z2016-08-26ALENCAR, L. C. B. Estudo de compatibilidade entre cafeína, dipirona e citrato de orfenadrina. 2016. 84f. Dissertação (Programa de Pós-Graduação em Ciências Farmacêuticas - PPGCF) - Universidade Estadual da Paraíba, Campina Grande, 2016.https://repositorio.uepb.edu.br/handle/123456789/7328424004014014P8The development of a new pharmaceutical form involves a number of preliminary analyzes, which constitute the pre-formulation study, which will be gathered information about the physical, chemical and mechanical properties of the formulation constituents. Therefore, it is necessary to investigate the compatibility of active pharmaceutical ingredients and excipients of the final product by means of thermoanalytical and non-thermal techniques as possible interactions can alter and compromise the efficacy, safety and quality of the product. Therefore, the primary objective of this study is to assess the compatibility of the active pharmaceutical inputs dipyrone, and caffeine citrate orfenandrina each other and excipients. The differential scanning calorimetry (DSC) was performed in ratios of 2, 5 and 10 ° C / min^-1, coupled with differential thermal analysis (DTA), infrared spectroscopy (FTIR) and x-ray diffraction (XRD). All DSC curves were obtained melting points of the active pharmaceutical ingredients, especi ally the values of the melting point found in the heating rate of 2 ° C / min, which were 237.75 ° C, 222.36 ° C and 140 , 41 ° C for caffeine, dipyrone and orphenadrine citrate, respectively. While, in the cooling curves was not identified any polymorphism. The quaternary DTA curves evaluated aerosil selection at the expense of pregelatinized starch and microcrystalline cellulose 101. From the curves of the binary mixture, those containing dipyrone showed greater mismatch indication, whereas the mixtures of the active pharmaceutical ingredients from themselves were compatible, since the characteristic peaks thereof were identified without changing considerably, its thermal events. In the infrared spectra there is a chemical interaction of carboxymethylcellulose with caffeine, moreover, the spectra containing the binary mixtures dipyrone there was suppression on the free hydroxyl bands glycolate starch, carboxymethylcellulose, starch and croscarmellose sodium, a similar result occurred with the starch glycolate opposite orphenadrine citrate. The XRD patterns did not identify displacement or removal of significant robins to characterize some sort of incompatibility. Through evaluation by different analytical techniques across the various preparations, it was observed that the IFA may be sold simultaneously in view of their physical and chemical compatibility.O desenvolvimento de uma nova forma farmacêutica envolve um conjunto de análises preliminares, que constituem o estudo de pré-formulação, onde serão reunidas informações a respeito das características físicas, químicas e mecânicas dos constituintes da formulação. Para tanto, faz-se necessário investigar a compatibilidade entre os insumos farmacêuticos ativos e os excipientes do produto final, por meio de técnicas termoanaliticas e não térmicas, visto que possíveis interações podem alterar e comprometer a eficácia, segurança e a qualidade do medicamento. Portanto, o objetivo precípuo desse estudo consiste em avaliar a compatibilidade dos insumos farmacêuticos ativos dipirona, cafeína e citrato de orfenandrina entre si e os excipientes. A calorimetria exploratória diferencial (DSC) foi realizada nas razões de 2, 5 e 10 °C/min^-1, aliada a análise térmica diferencial (DTA), espectroscopia de infravermelho(FTIR) e difração de -1 , aliada a raio X (DRX). Nas curvas de DSC foram obtidos os pontos de fusão dos insumos farmacêuticos ativos, destacando-se os valores do ponto de fusão encontrados na razão de aquecimento de 2 °C/min, que foram de 237,75 ºC, 222,36 ºC e 140,41 ºC para cafeína, dipirona e citrato de orfenadrina, respectivamente. Enquanto que, nas curvas de resfriamento não foi identificado nenhum tipo de polimorfismo. As curvas quaternárias da DTA avaliaram a seleção do aerosil em detrimento do amido pre-gelatinizado e celulose microcristalina 101. A partir das curvas das mistura binárias, as que continham dipirona apresentaram maiores indícios de incompatibilidade, enquanto que, as misturas dos insumos farmacêuticos ativos entre si foram compatíveis, uma vez que os picos característicos dos mesmos foram identificados sem alterar, consideravelmente, seus eventos térmicos. Nos espectros de infravermelho verificou-se interação química da carboximetilcelulose com a cafeína, além disso, nos espectros contendo as misturas binarias de dipirona houve supressão nas bandas de hidroxila livre de amido glicolato, carboximetilcelulose, amido e croscarmelose sódica, resultado semelhante ocorreu com o amido glicolato frente ao citrato de orfenadrina. Os difratogramas não identificaram deslocamentos ou supressão de piscos significantes para caracterizar algum tipo de incompatibilidade. Por meio da avaliação por diferentes técnicas analíticas frente a várias preparações, foi observado que os IFA podem ser comercializados concomitantemente, tendo em vista a sua compatibilidade física e química.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESapplication/pdfUniversidade Estadual da ParaíbaPrograma de Pós-Graduação em Ciências Farmacêuticas - PPGCFUEPBBRPró-Reitoria de Pós-Graduação e Pesquisa - PRPGPPró-Reitoria de Pós-Graduação e Pesquisa - PRPGPAnalytical techniquesDipyroneCaffeineOrphenadrine citrateCIENCIAS DA SAUDECompatibilidade químicaTécnicas analíticasDipironaCafeínaCitrato de orfenadrinaEstudo de compatibilidade entre cafeína, dipirona e citrato de orfenadrinaCase study on the topic of desalination in high school: an argumentative analysis on the content solutionsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisPinto, Márcia Ferrazhttp://lattes.cnpq.br/4742844844505300Correia, Lidiane Pintohttp://lattes.cnpq.br/2840534011411431Medeiros, Ana Claudia Dantas dehttp://lattes.cnpq.br/0640671064146120http://lattes.cnpq.br/8264525969795955Alencar, Laianne Carla Batistainfo:eu-repo/semantics/openAccessporreponame:Repositório Institucional da Universidade Estadual da Paraíba (UEPB)instname:Universidade Estadual da Paraíba (UEPB)instacron:UEPBLICENSElicense.txtlicense.txttext/plain; charset=utf-81960https://repositorio.uepb.edu.br/bitstreams/8dd26844-d6ec-47e5-b232-5b6dafef728c/download6052ae61e77222b2086e666b7ae213ceMD51falseAnonymousREADlicense.txtlicense.txttext/plain; charset=utf-81324https://repositorio.uepb.edu.br/bitstreams/383546b9-1c7a-48f0-9edc-e40c8a5e1906/downloadea12793326f265c7d8ea2bcdd2c49d6fMD55falseAnonymousREADORIGINALPDF - Laianne Carla Batista Alencar.pdfPDF - Laianne Carla Batista Alencar.pdfPDF - Laianne Carla Batista Alencarapplication/pdf76493536https://repositorio.uepb.edu.br/bitstreams/87cae588-f614-4ba9-a7ad-9644a05d9061/download81979c4a19d0b51b9825af83908d898cMD52trueAnonymousREADTEXTPDF - Laianne Carla Batista Alencar.pdf.txtPDF - Laianne Carla Batista Alencar.pdf.txtExtracted Texttext/plain86https://repositorio.uepb.edu.br/bitstreams/e78dddba-61f9-41c5-ab52-2d129b5776b2/downloade6cc0aadcc647aee77937501ab3b5c08MD53falseAnonymousREADTHUMBNAILPDF - Laianne Carla Batista Alencar.pdf.jpgPDF - Laianne Carla Batista Alencar.pdf.jpgGenerated Thumbnailimage/jpeg3357https://repositorio.uepb.edu.br/bitstreams/802b0298-72a1-433a-80ed-9eec32399d7c/download0dc9c165969d41d582e7835d802378f3MD54falseAnonymousREAD123456789/732842026-05-06T11:51:55.338647Zopen.accessoai:repositorio.uepb.edu.br:123456789/73284https://repositorio.uepb.edu.brRepositório InstitucionalPUBhttp://dspace.bc.uepb.edu.br/oai/requestsibuepb@setor.uepb.edu.bropendoar:2026-05-06T11:51:55Repositório Institucional da Universidade Estadual da Paraíba (UEPB) - Universidade Estadual da Paraíba (UEPB)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 |
| dc.title.none.fl_str_mv |
Estudo de compatibilidade entre cafeína, dipirona e citrato de orfenadrina |
| dc.title.alternative.eng.fl_str_mv |
Case study on the topic of desalination in high school: an argumentative analysis on the content solutions |
| title |
Estudo de compatibilidade entre cafeína, dipirona e citrato de orfenadrina |
| spellingShingle |
Estudo de compatibilidade entre cafeína, dipirona e citrato de orfenadrina Alencar, Laianne Carla Batista Analytical techniques Dipyrone Caffeine Orphenadrine citrate CIENCIAS DA SAUDE Compatibilidade química Técnicas analíticas Dipirona Cafeína Citrato de orfenadrina |
| title_short |
Estudo de compatibilidade entre cafeína, dipirona e citrato de orfenadrina |
| title_full |
Estudo de compatibilidade entre cafeína, dipirona e citrato de orfenadrina |
| title_fullStr |
Estudo de compatibilidade entre cafeína, dipirona e citrato de orfenadrina |
| title_full_unstemmed |
Estudo de compatibilidade entre cafeína, dipirona e citrato de orfenadrina |
| title_sort |
Estudo de compatibilidade entre cafeína, dipirona e citrato de orfenadrina |
| author |
Alencar, Laianne Carla Batista |
| author_facet |
Alencar, Laianne Carla Batista |
| author_role |
author |
| dc.contributor.referee1.fl_str_mv |
Pinto, Márcia Ferraz |
| dc.contributor.referee1Lattes.fl_str_mv |
http://lattes.cnpq.br/4742844844505300 |
| dc.contributor.referee2.fl_str_mv |
Correia, Lidiane Pinto |
| dc.contributor.referee2Lattes.fl_str_mv |
http://lattes.cnpq.br/2840534011411431 |
| dc.contributor.advisor1.fl_str_mv |
Medeiros, Ana Claudia Dantas de |
| dc.contributor.advisor1Lattes.fl_str_mv |
http://lattes.cnpq.br/0640671064146120 |
| dc.contributor.authorLattes.fl_str_mv |
http://lattes.cnpq.br/8264525969795955 |
| dc.contributor.author.fl_str_mv |
Alencar, Laianne Carla Batista |
| contributor_str_mv |
Pinto, Márcia Ferraz Correia, Lidiane Pinto Medeiros, Ana Claudia Dantas de |
| dc.subject.eng.fl_str_mv |
Analytical techniques Dipyrone Caffeine Orphenadrine citrate |
| topic |
Analytical techniques Dipyrone Caffeine Orphenadrine citrate CIENCIAS DA SAUDE Compatibilidade química Técnicas analíticas Dipirona Cafeína Citrato de orfenadrina |
| dc.subject.cnpq.fl_str_mv |
CIENCIAS DA SAUDE |
| dc.subject.por.fl_str_mv |
Compatibilidade química Técnicas analíticas Dipirona Cafeína Citrato de orfenadrina |
| description |
The development of a new pharmaceutical form involves a number of preliminary analyzes, which constitute the pre-formulation study, which will be gathered information about the physical, chemical and mechanical properties of the formulation constituents. Therefore, it is necessary to investigate the compatibility of active pharmaceutical ingredients and excipients of the final product by means of thermoanalytical and non-thermal techniques as possible interactions can alter and compromise the efficacy, safety and quality of the product. Therefore, the primary objective of this study is to assess the compatibility of the active pharmaceutical inputs dipyrone, and caffeine citrate orfenandrina each other and excipients. The differential scanning calorimetry (DSC) was performed in ratios of 2, 5 and 10 ° C / min^-1, coupled with differential thermal analysis (DTA), infrared spectroscopy (FTIR) and x-ray diffraction (XRD). All DSC curves were obtained melting points of the active pharmaceutical ingredients, especi ally the values of the melting point found in the heating rate of 2 ° C / min, which were 237.75 ° C, 222.36 ° C and 140 , 41 ° C for caffeine, dipyrone and orphenadrine citrate, respectively. While, in the cooling curves was not identified any polymorphism. The quaternary DTA curves evaluated aerosil selection at the expense of pregelatinized starch and microcrystalline cellulose 101. From the curves of the binary mixture, those containing dipyrone showed greater mismatch indication, whereas the mixtures of the active pharmaceutical ingredients from themselves were compatible, since the characteristic peaks thereof were identified without changing considerably, its thermal events. In the infrared spectra there is a chemical interaction of carboxymethylcellulose with caffeine, moreover, the spectra containing the binary mixtures dipyrone there was suppression on the free hydroxyl bands glycolate starch, carboxymethylcellulose, starch and croscarmellose sodium, a similar result occurred with the starch glycolate opposite orphenadrine citrate. The XRD patterns did not identify displacement or removal of significant robins to characterize some sort of incompatibility. Through evaluation by different analytical techniques across the various preparations, it was observed that the IFA may be sold simultaneously in view of their physical and chemical compatibility. |
| publishDate |
2016 |
| dc.date.issued.fl_str_mv |
2016-08-26 |
| dc.date.accessioned.fl_str_mv |
2018-04-23T20:27:02Z 2026-02-27T10:26:53Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
| format |
masterThesis |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
ALENCAR, L. C. B. Estudo de compatibilidade entre cafeína, dipirona e citrato de orfenadrina. 2016. 84f. Dissertação (Programa de Pós-Graduação em Ciências Farmacêuticas - PPGCF) - Universidade Estadual da Paraíba, Campina Grande, 2016. |
| dc.identifier.uri.fl_str_mv |
https://repositorio.uepb.edu.br/handle/123456789/73284 |
| dc.identifier.capesdegreeprogramcode.none.fl_str_mv |
24004014014P8 |
| identifier_str_mv |
ALENCAR, L. C. B. Estudo de compatibilidade entre cafeína, dipirona e citrato de orfenadrina. 2016. 84f. Dissertação (Programa de Pós-Graduação em Ciências Farmacêuticas - PPGCF) - Universidade Estadual da Paraíba, Campina Grande, 2016. 24004014014P8 |
| url |
https://repositorio.uepb.edu.br/handle/123456789/73284 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Universidade Estadual da Paraíba |
| dc.publisher.program.fl_str_mv |
Programa de Pós-Graduação em Ciências Farmacêuticas - PPGCF |
| dc.publisher.initials.fl_str_mv |
UEPB |
| dc.publisher.country.fl_str_mv |
BR |
| dc.publisher.department.fl_str_mv |
Pró-Reitoria de Pós-Graduação e Pesquisa - PRPGP Pró-Reitoria de Pós-Graduação e Pesquisa - PRPGP |
| publisher.none.fl_str_mv |
Universidade Estadual da Paraíba |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da Universidade Estadual da Paraíba (UEPB) instname:Universidade Estadual da Paraíba (UEPB) instacron:UEPB |
| instname_str |
Universidade Estadual da Paraíba (UEPB) |
| instacron_str |
UEPB |
| institution |
UEPB |
| reponame_str |
Repositório Institucional da Universidade Estadual da Paraíba (UEPB) |
| collection |
Repositório Institucional da Universidade Estadual da Paraíba (UEPB) |
| bitstream.url.fl_str_mv |
https://repositorio.uepb.edu.br/bitstreams/8dd26844-d6ec-47e5-b232-5b6dafef728c/download https://repositorio.uepb.edu.br/bitstreams/383546b9-1c7a-48f0-9edc-e40c8a5e1906/download https://repositorio.uepb.edu.br/bitstreams/87cae588-f614-4ba9-a7ad-9644a05d9061/download https://repositorio.uepb.edu.br/bitstreams/e78dddba-61f9-41c5-ab52-2d129b5776b2/download https://repositorio.uepb.edu.br/bitstreams/802b0298-72a1-433a-80ed-9eec32399d7c/download |
| bitstream.checksum.fl_str_mv |
6052ae61e77222b2086e666b7ae213ce ea12793326f265c7d8ea2bcdd2c49d6f 81979c4a19d0b51b9825af83908d898c e6cc0aadcc647aee77937501ab3b5c08 0dc9c165969d41d582e7835d802378f3 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da Universidade Estadual da Paraíba (UEPB) - Universidade Estadual da Paraíba (UEPB) |
| repository.mail.fl_str_mv |
sibuepb@setor.uepb.edu.br |
| _version_ |
1865082748670050304 |